Dry powder aerosol containing muco-inert particles for excipient enhanced growth pulmonary drug delivery.

Nanomedicine 2020 10 3;29:102262. Epub 2020 Jul 3.

Department of Pharmaceutics, Virginia Commonwealth University, Richmond, VA, USA; Department of Ophthalmology, Massey Cancer Center, Center for Pharmaceutical Engineering, and Institute for Structural Biology, Drug Discovery & Development (ISB3D), Virginia Commonwealth University, Richmond, VA, USA. Electronic address:

Tenacious sputum poses a critical diffusion barrier for aerosol antibiotics used to treat cystic fibrosis (CF) lung infection. We conducted a proof-of-concept study using dense poly(ethylene glycol) coated polystyrene nanoparticles (PS-PEG NPs) as model muco-inert particles (MIPs) formulated as a powder using an excipient enhanced growth (EEG) strategy, aiming to minimize extrathoracic airway loss, maximize deposition in the airway and further overcome the sputum barrier in the CF lungs. The EEG aerosol formulation containing PS-PEG MIPs was prepared by spray drying and produced discrete spherical particles with geometric diameter of approximately 2 μm; and >80% of the powder dose was delivered from a new small-animal dry powder inhaler (DPI). The MIPs released from the EEG aerosol had human airway mucus and CF sputum diffusion properties comparable to the suspension formulation. These properties make this formulation a promising pulmonary drug delivery system for CF lung infections.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nano.2020.102262DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508849PMC
October 2020

Publication Analysis

Top Keywords

excipient enhanced
8
enhanced growth
8
drug delivery
8
eeg aerosol
8
muco-inert particles
8
pulmonary drug
8
dry powder
8
aerosol formulation
4
lungs eeg
4
barrier lungs
4
overcome sputum
4
sputum barrier
4
formulation ps-peg
4
ps-peg mips
4
produced discrete
4
discrete spherical
4
drying produced
4
spray drying
4
mips prepared
4
prepared spray
4

Similar Publications